Articles on this page are updated by ProfileData Research on an hourly basis. To see the summary of the SENS notice, please click on the headline. To read the original SENS message, please click on the link in the summary.
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Archive
Date
Headline/Title
11 December 2009
Appointment Of Director
04 December 2009
Results Of Annual General Meeting
01 December 2009
Completion of multiple strategic inter
03 November 2009
Completion Of Multiple Strategic Inter - Dependant Transactions
03 November 2009
Change Statement And Notice Of Annual General Meeting
21 October 2009
Directors Dealings
22 September 2009
Directors dealings
08 September 2009
Aspen final results June 09
08 September 2009
Aspen`s revenue increases by 80
08 September 2009
Aspen Holdings - Reviewed preliminary Group financial results for the year
01 September 2009
Trading Update
29 June 2009
Director`s Dealings
24 June 2009
Director Dealings in shares
24 June 2009
Dealings in Securities
12 June 2009
Official Statement Regarding the Alleged
12 May 2009
Aspen and GSK agree on multiple
26 March 2009
Renewal of cautionary announcement
05 March 2009
Aspen interim results December 08
05 March 2009
Aspen`s Offshore Operations Drive An Impressive 91% Revenue Increase
05 March 2009
Interim Financial Results For The Six Months Ended 31 December
02 March 2009
Resignation of non-executive director
19 February 2009
Renewal Of Cautionary Announcement
12 February 2009
Trading update
30 January 2009
Servier And Aspen Sign Technology Transfer Mou
13 January 2009
Cautionary announcement
13 January 2009
Cautionary announcement
10 December 2008
Director`s dealings
03 December 2008
Dealings in securities
03 December 2008
Director`s dealings
28 November 2008
Results Of Annual General Meeting
07 November 2008
Posting Of Annual Report And Notice Of Annual General Meeting
29 October 2008
Director`s Dealings
24 October 2008
Directors` Dealings
16 October 2008
Finalisation Of Term Loan Funding Facility
09 October 2008
Voluntary Transaction Announcement
03 October 2008
Director`s dealings
16 September 2008
Aspen final results June 08
16 September 2008
Aspen establishes its international platform for future growth
16 September 2008
Aspen Holdings - Reviewed preliminary Group financial results for the
16 September 2008
Revision Of Terms Of Aspen`s Investment In Strides` Latin American
26 August 2008
New appointment to the board of
23 July 2008
Aspen businesses in licensing deal with GSK
16 July 2008
Withdrawal Of Cautionary Announcement
30 June 2008
Worldwide acquisition of brands by
26 June 2008
Anti-Retroviral Tender Results
06 June 2008
Cautionary announcement
23 May 2008
Director
14 May 2008
Director
05 May 2008
Voluntary announ
31 March 2008
Company announcement - Directorate
25 February 2008
Aspen interim results December 07
25 February 2008
Aspen records 15% year-on-year revenue increase
25 February 2008
ASPEN - Unaudited interim financial results for the six months ended 31
20 February 2008
Change in directorate
20 November 2007
Transact
20 November 2007
Aspen Pharmacare Holding Limited - Press Rel
20 November 2007
Transact
16 November 2007
Results
16 November 2007
Cautiona
06 November 2007
Dealings
11 October 2007
Posting of annual report and notice
19 September 2007
Dealing In Secur
20 August 2007
Capital Distribution
20 August 2007
Aspen final results June 07
20 August 2007
Press re
20 August 2007
Reviewed preliminary group financial
22 June 2007
Dealing
11 June 2007
Dr Judy Dlamini Appointed Chairman D
08 June 2007
Director`s Dealings
04 June 2007
Director
24 April 2007
Key Arv Products Viread* And Truvada
23 April 2007
Dealings In Securities
19 April 2007
Directors Dealin
04 April 2007
Tibotec and Aspen Collaborate on Pre
26 February 2007
Aspen interim results December 06
26 February 2007
Press Re
26 February 2007
Interim financial results: six month
15 February 2007
Appointment of alternate director
12 February 2007
Trading
19 January 2007
Aspen And Lupin Decide Not To Progre
16 November 2006
Results of Ann
11 October 2006
Posting Of Annual Report And Notice Of Ann
05 September 2006
Appointment of
30 August 2006
Dealing in sha
21 August 2006
Aspen final results June 06
21 August 2006
Press Release
21 August 2006
Aspen-Reviewed Preliminary Group Financial Results
19 July 2006
Trading Statem
15 June 2006
Withdrawal Of
31 May 2006
Cautionary ann
16 May 2006
Aspen to manufacture influenza medicine
08 May 2006
Resignation Of Director
20 March 2006
Dealing in shares by a director of a major
09 March 2006
Dealings in se
27 February 2006
Aspen Signs MO
27 February 2006
Aspen interim results December 05
27 February 2006
Press Release
27 February 2006
Interim financial results for the six mont
23 February 2006
Appointment of
16 February 2006
Aspen and BMS conclude strategic ARV deal
09 February 2006
TRADING STATEM
09 January 2006
Directorate
25 November 2005
Director Deali
08 November 2005
Dealing in Aspen Pharmacare Holdings Limit
07 November 2005
Announcement
26 October 2005
Results Of Ann
03 October 2005
Dealing in shares by a director of a subsi
03 October 2005
Dealing in shares by a director of a subsi
03 October 2005
No change statement and notice of annual g
03 October 2005
No change statement and notice of annual g
26 September 2005
Aspen And Lupin Sign TB Deal
23 September 2005
Aspen and Indias Matrix sign JVs
13 September 2005
Director dealings in shares
26 August 2005
Aspen Pharmacare Holdings Limited
22 August 2005
Aspen Pharmacare Holdings Ltd - Press release
22 August 2005
Aspen final results June 05
27 July 2005
Clarification
21 July 2005
Trading Statem
21 July 2005
Trading Statem
19 July 2005
MSD grants Aspen generic ARV license
19 July 2005
MSD grants Aspen generic ARV license
15 July 2005
Appointment Of Director
21 June 2005
Aspen Pharmacare Holdings Ltd - Director dealing i
20 June 2005
Dealing In Shares By A Director
15 June 2005
Scheme Of Arrangement
15 June 2005
Scheme Of Arrangement
15 June 2005
Directors Dealings
07 June 2005
Sanctioning by the high court of the Aspen
30 May 2005
Results Of The Aspen General And Scheme Meetings
30 May 2005
Results Of The Aspen General And Scheme Meetings
06 May 2005
Order Of Court
06 May 2005
Salient Dates In Respect Of The Proposed S
06 May 2005
Salient Dates In Respect Of The Proposed S
25 April 2005
Aspen and US-based Gilead
25 April 2005
Aspen and US-based Gilead
20 April 2005
Dealing In Shares By A Director
08 April 2005
Aspen signs MOU with Indian based Matrix
17 March 2005
Proposed Introduction Of Additional Black
17 March 2005
Proposed Introduction Of Additional Black
04 March 2005
Aspen awarded
04 March 2005
Aspen awarded
21 February 2005
Interim financial results for the six months ende
21 February 2005
Aspen interim results December 04
15 February 2005
BLACK ECONOMIC EMPOWERMENT (BEE) TRANSACTION
01 February 2005
TRADING STATEMENT
28 January 2005
Aspen shares continue to surge
25 January 2005
ADDRESS BY STEPHEN SAAD, ASPEN PHARMACARE
14 December 2004
Withdrawal of cautionary announcement
14 December 2004
Withdrawal of cautionary announcement
13 December 2004
Aspen To Supply Us Government With Generic ARVs
13 December 2004
Aspen To Supply Us Government With Generic ARVs
22 November 2004
RENEWAL OF CAUTIONARY ANNOUNCEMENT
22 November 2004
RENEWAL OF CAUTIONARY ANNOUNCEMENT
18 November 2004
DEALINGS IN SECURITIES
16 November 2004
Aspen chief enjoys 55% pay rise after good results
05 October 2004
Renewal of cautionary announcement
01 October 2004
NO CHANGE STATEMENT AND NOTICE OF AGM
08 September 2004
Aspen To Supply US Government
08 September 2004
Aspen To Supply US Government
18 August 2004
Financial Results For The Year Ended 30 June 04
18 August 2004
Aspen results for the year ended 30 June 04
10 August 2004
APPOINTMENT OF EXECUTIVE DIRECTOR
10 August 2004
APPOINTMENT OF EXECUTIVE DIRECTOR
29 July 2004
Announcement
29 July 2004
Announcement
27 July 2004
Results Of General Meeting
13 July 2004
ACQUISITION OF FINE CHEMICALS
13 July 2004
Trading statement and cautionary announcement
24 June 2004
Proposed Specific Share Repurchase
24 June 2004
Proposed Specific Share Repurchase
15 June 2004
Aspen enters the infant nutritional market
13 May 2004
Resignation Of Chief Operating Officer
13 May 2004
Resignation Of Chief Operating Officer
06 May 2004
CAUTIONARY ANNOUNCEMENT
10 March 2004
Acquisition By Aspen Of Fine Chemicals
03 March 2004
Dealing In Securities By Director
17 February 2004
Aspen results for the 6 months ended 31 Dec 03
17 February 2004
INTERIM RESULTS AND WITHDRAWAL OF CAUTIONARY
05 February 2004
News release
15 January 2004
TRADING STATEM
15 January 2004
TRADING STATEM
14 November 2003
RESULTS OF GENERAL MEETING
24 October 2003
Aspen to manuf
24 October 2003
Aspen to manuf
01 October 2003
ASPEN - DIRECTORS DEALINGS
23 September 2003
Changes to the Board
25 August 2003
Directors dealing
20 August 2003
Aspen results for the year ended 30 June 03
14 August 2003
Aspen gains from state AIDS plan
06 August 2003
Aspen manufactures Africas first generic ARVs
06 May 2003
Aspen Pharmacare - press release
26 March 2003
Aspen arrangemnt with GlaxoSmithKline
26 March 2003
Aspen Pharmacare to distribute 40 GlaxoSmithKline
12 March 2003
PHARMACARE HOLDINGS LIMITED
17 February 2003
Aspen results for 6 months ended 31 Dec 02
13 December 2002
Aspen/Peu - Announcement
20 November 2002
Directors Deal
30 October 2002
PRESS RELEASE
29 October 2002
Aspen Pharmacare Holdings Limited - Dealing in Se
25 October 2002
Directors dealing
21 October 2002
Directors deal
17 October 2002
Aspen Pharmacare - Directors Dealing
15 October 2002
Aspen Pharmacare - Press Release
15 October 2002
Aspen Pharmacare - Press Release
21 August 2002
Aspen results for the 12 months ended 30 Jun 02
31 May 2002
Change In Directorate
22 April 2002
Aspen to benefit from States new AIDS stance
20 March 2002
Directors Deal
07 March 2002
Aspen in Novartis deal
19 February 2002
Directors Dealing
12 February 2002
Aspen results for 6 months ended 31 Dec 01
31 January 2002
Acquisition By Ceppwawu Pharmaceutical Investments
31 January 2002
Dealing In Shares By Directors
20 November 2001
Directors Disclosure
08 October 2001
Aspen receives rights to Aids drugs from GSK
27 September 2001
Aspen Pharmacare & Merck Generics (rsa) - Enter In
24 August 2001
Purchase Of Sh
22 August 2001
Aspen results for 12 months ended 30 Jun 01
17 August 2001
Changes To The
18 July 2001
Aspen Company Announcement
04 July 2001
Press Release
18 June 2001
Aspen Strate take on
21 May 2001
Aspen in deal with Tibett & Britten
30 March 2001
Aspen share repurchase
07 March 2001
Dealing In Sha
15 February 2001
Aspen results for 6 months ended 31 Dec 00
21 December 2000
Aspen acquires Co-Pharma
12 December 2000
Aspen AFSs qualified
12 December 2000
Aspen response to qualification of AFSs
14 September 2000
Aspen results for 12 months ended 30 Jun 00
20 June 2000
Aspen subsidiaries make various disposals
17 February 2000
Aspen results for 6 months ended 31 Dec 99
17 February 2000
Results of general meeting
27 January 2000
Aspen to change name
25 October 1999
Aspen disposes of Lagap Pharmaceuticals
27 September 1999
Aspen releases finals for 30 June 99
21 September 1999
Aspen issues cautionary
25 June 1999
Aspen acquires own shares & reduces share premium
23 March 1999
Aspen finalises proposals regarding SAD
10 March 1999
Aspen consortium nears agreement with SAD
16 February 1999
Aspen makes offer 4 SAD pharmaceutical business
12 February 1999
Aspen issues cautionary
01 February 1999
Aspen acquires Columbia Pharmaceuticals
29 January 1999
Aspen makes a minority offer
12 August 1998
Medhold has acquired Aspen Health Care and Attwell
14 July 1998
Medhold has acquired Aspen Health Care and Attwell
03 July 1998
Further cautionary
15 May 1998
Further cautionary
24 March 1998
Cautionary announcement
04 November 1996
1:2 consolidation during period to April 1995
Powered by
ProfileData